News & Events

news

Investitionsbank Sachsen-Anhalt grants fund for Nomad´s research project „Use of non-antibiotic antimicrobial proteins (colicins) for control of pathogenic salmonellae“

Investitionsbank Sachsen-Anhalt grants fund for Nomad´s research project „Use of non-antibiotic antimicrobial proteins (colicins) for control of pathogenic salmonellae“ Die…

Investitionsbank Sachsen-Anhalt grants fund for Nomad´s research project „Use of non-antibiotic antimicrobial proteins (colicins) for control of multi resistant Escherichia coli (MREC)“

Investitionsbank Sachsen-Anhalt grants fund for Nomad´s research project „Use of non-antibiotic antimicrobial proteins (colicins) for control of multi resistant Escherichia coli (MREC)“…

NOMAD Bioscience enters into agreement with Monsanto

NOMAD Bioscience enters into agreement with Monsanto Monsanto Company (NYSE: MON) and Nomad Bioscience GmbH have announced a licensing agreement…

NOMAD Bioscience Receives its First Regulatory Allowance in USA

NOMAD Bioscience Receives its First Regulatory Allowance in USA Munich, Germany, December 19, 2015. NOMAD Bioscience received a formal ‘no…

NOMAD Bioscience Published Milestone Research Paper Describing its Colicin Product Candidates

NOMAD Bioscience Published Milestone Research Paper Describing its Colicin Product Candidates NOMAD Bioscience announces the publication in the Proceedings of…

Denka Seiken: Announcement of Acquisition of Shares (Ownership) in ICON Genetics GmbH, a German Bio-pharmaceutical R&D Company

Denka Seiken: Announcement of Acquisition of Shares (Ownership) in ICON Genetics GmbH, a German Bio-pharmaceutical R&D Company Company Name: DENKI…

NOMAD Bioscience Published Milestone Research Paper Describing its NOMADIC™ Expression Technology

NOMAD Bioscience Published Milestone Research Paper Describing its NOMADIC™ Expression Technology December 2014 – NOMAD Bioscience announces the publication in…

NOMAD Bioscience and ICON Genetics sign broad cross-license agreement

NOMAD Bioscience and ICON Genetics sign broad cross-license agreement Munich, March 15, 2012 – NOMAD Bioscience GmbH, Munich, Germany (NOMAD)…

NOMAD Bioscience enters into comprehensive agreement with Bayer Innovation

NOMAD Bioscience enters into comprehensive agreement with Bayer Innovation Munich, January 12, 2012 – NOMAD Bioscience GmbH, Munich, Germany (NOMAD)…

NOMAD Bioscience announces broad license agreement

NOMAD Bioscience announces broad license agreement Munich, Germany, September 2008 – Nomad Bioscience GmbH announces that it entered into a…